Risk of depression in patients with inflammatory bowel disease.

Autor: Geiss T; Department of Gastroenterology and Hepatology, University Hospital Heidelberg, Heidelberg, Germany., Schaefert RM; Department of Psychosomatics, University Hospital Basel, Basel, Switzerland.; Department of General Internal Medicine and Psychosomatics, University of Heidelberg, Heidelberg, Germany., Berens S; Department of General Internal Medicine and Psychosomatics, University of Heidelberg, Heidelberg, Germany., Hoffmann P; Department of Gastroenterology and Hepatology, University Hospital Heidelberg, Heidelberg, Germany., Gauss A; Department of Gastroenterology and Hepatology, University Hospital Heidelberg, Heidelberg, Germany.
Jazyk: angličtina
Zdroj: Journal of digestive diseases [J Dig Dis] 2018 Aug; Vol. 19 (8), pp. 456-467. Date of Electronic Publication: 2018 Aug 23.
DOI: 10.1111/1751-2980.12644
Abstrakt: Objective: Depression is more prevalent in patients with inflammatory bowel disease (IBD) than in the general population. This study evaluated disease-related risk factors for depression in Crohn's disease (CD) and ulcerative colitis (UC).
Methods: Altogether 348 patients with IBD (228 with CD, 120 with UC) were included at our Outpatient IBD Clinic. Their characteristics, laboratory results and scores of depression, quality of life and clinical disease activity were retrospectively retrieved from questionnaires and medical records. The patient health questionnaire 9 (PHQ-9) was used as an algorithm for a probable diagnosis of major depression employing a cut-off point ≥10. Logistic regression analyses were performed to identify risk factors for depression.
Results: Among these patients, 163 (46.8%) had no or minimal depression (PHQ-9 score 0-4), 108 (31.0%) had mild depression (PHQ-9 score 5-9) and 77 (22.1%) were at risk of major depression (PHQ-9 score ≥10). Patients with CD had a higher risk of major depression than those with UC (25.4% vs 15.8%, P = 0.040). PHQ-9 scores correlated strongly with clinical disease activity and quality of life scores in both groups but only weakly and solely in the CD group with biochemical disease activity. Clinical disease activity was identified as the only independent risk factor for depression in CD (odds ratio 7.814, 95% CI 2.688-22.717, P < 0.001), while no independent risk factor for depression was detected in UC.
Conclusion: Achieving clinical remission in patients with IBD seems to be the most important factor to reduce the risk of depression.
(© 2018 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje